Progestational agents prevent preterm birth induced by a nitric oxide synthesis inhibitor in the mouse

In Vivo

Volumn 22, Issue 4, 2008, Pages 447-450

  Tiboni, Gian Mario ^a   Del Corso, Antonio ^a   Marotta, Francesca ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Inhibition of nitric oxide synthesis; Nitric oxide; Preterm birth; Progestational agents

Indexed keywords

GESTAGEN; HYDROXYPROGESTERONE CAPROATE; MEDROXYPROGESTERONE ACETATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GESTATIONAL AGE; MOUSE; NONHUMAN; PREMATURE LABOR;

EID: 48349140198     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Smith R: Parturition. N Engl J Med 356: 271-283, 2007.
2. Maul H, Longo M, Saade GR and Garfield RE: Nitric oxide and its role during pregnancy: from ovulation to delivery. Curr Pharm Des 9: 359-380, 2003.
3. Moncada S, Higgs A and Furchgott R: International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev 49: 137-142, 1997.
4. Hobbs AJ, Higgs A and Moncada S: Inhibition of nitric oxide synthase as a potential therapeutic target. Ann Rev Pharmacol Toxicol 39: 191-220, 1999.
5. Tiboni GM and Giampietro F: Inhibition of nitric oxide synthesis causes preterm delivery in the mouse. Human Reprod 15: 1838-1842, 2000.
6. ω-nitro-L-arginine methyl ester (L-NAME) causes limb defects in mouse fetuses: protective effect of acute hyperoxia. Pediatr Res 54: 69-76, 2003.
7. Mackenzie R, Walker M, Armson A and Hannah ME: Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 194: 1234-1242, 2006.
8. Buhimschi I, Ali M, Jain V, Chwalisz K and Garfield RE: Differential regulation of nitric oxide in the rat uterus and cervix during pregnancy and labour. Hum Reprod 11: 1755-1766, 1996.
9. Purcell TL, Buhimschi IA, Given R, Chwalisz K and Garfield RE: Inducible nitric oxide synthase is present in the rat placenta at the fetal-maternal interface and decreases prior to labour. Mol Hum Reprod 3: 485-491, 1997.
10. Ali M, Buhimschi I, Chwalisz K and Garfield RE: Changes in expression of the nitric oxide synthase isoforms in rat uterus and cervix during pregnancy and parturition. Mol Hum Reprod 3: 995-1003, 1997.
11. Huang J, Roby KF, Pace JL, Russell SW and Hunt JS: Cellular localization and hormonal regulation of inducible nitric oxide synthase in cycling mouse uterus. J Leukoc Biol 57: 27-35, 1995.
12. Dong YL, Fang L, Gangula PR and Yallampalli C: Regulation of inducible nitric oxide synthase messenger ribonucleic acid expression in pregnant rat uterus. Biol Reprod 59: 933-940, 1998.
13. Ogando D, Farina M, Ribeiro ML, Perez Martinez S, Cella M, Rettori V and Franchi A: Steroid hormones augment nitric oxide synthase activity and expression in rat uterus. Reprod Fert Dev 15: 269-274, 2003.
14. Little B, Billiar RB, Rahman SS, Johnson WA, Takaoka Y and White RJ: In vivo aspects of progesterone distribution and metabolism. Am J Obstet Gynecol 123: 527-534, 1975.
15. Tiboni GM, Giampietro F and Lamonaca D: The soluble guanylate cyclase inhibitor methylene blue evokes preterm delivery and fetal growth restriction in a mouse model. In Vivo 15: 333-337, 2001.
16. Yallampalli C, Buhimschi I, Chwalisz K, Garfield RE and Dong YL: Preterm birth in rats produced by the synergistic action of a nitric oxide inhibitor (NG-nitro-L-arginine methyl ester) and an antiprogestin (onapristone). Am J Obstet Gynecol 175: 207-212, 1996.
17. Mesiano S: Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 11: 193-202, 2004.